Patient Guide: A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 116 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT04541810
Status: 🟢 Enrolling Now
Condition: Rheumatoid Arthritis (RA), Atopic Dermatitis (AD), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA)
Phase: Research Study

Where You Can Participate

This study is available at 116 locations across the country.

Top locations include:
  • • Busan, Busan Gwang Yeogsi
  • • Busan, Busan Gwang Yeogsi
  • • Busan, Busan Gwang Yeogsi
  • • And 113 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Oral Upadacitinib (RINVOQ) Tablets to Assess Adverse Events and Change in Disease Symptoms in Korean Participants With Moderate to Severe Active Rheumatoid Arthritis, Atopic Dermatitis, Ankylosing Spondylitis or Psoriatic Arthritis - Join Clinical Trial NCTNCT04541810

How to Join This Clinical Trial - NCTNCT04541810

Learn how to participate in this clinical trial studying an investigational therapy for Rheumatoid Arthritis (RA), Atopic Dermatitis (AD), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA). This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Rheumatoid Arthritis (RA), Atopic Dermatitis (AD), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA). Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Rheumatoid Arthritis (RA), Atopic Dermatitis (AD), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA)
Treatment Being Tested
Investigational treatment
Study Phase
Clinical trial phase - Research study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT04541810 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 116 locations. Find a study site near you:

Clinical Research Site

Busan, Busan Gwang Yeogsi 47392 - Korea, Republic of

Status: RECRUITING

Clinical Research Site

Busan, Busan Gwang Yeogsi 48059 - Korea, Republic of

Status: RECRUITING

Clinical Research Site

Busan, Busan Gwang Yeogsi 48108 - Korea, Republic of

Status: RECRUITING

Clinical Research Site

Busan, Busan Gwang Yeogsi 49241 - Korea, Republic of

Status: RECRUITING

Clinical Research Site

Busan, Busan Gwang Yeogsi 49267 - Korea, Republic of

Status: RECRUITING

Clinical Research Site

Cheongju, Chungcheongbugdo 28644 - Korea, Republic of

Status: RECRUITING

Clinical Research Site

Cheongju, Chungcheongbugdo 28644 - Korea, Republic of

Status: RECRUITING

Clinical Research Site

Chungbuk, Chungcheongbugdo 28641 - Korea, Republic of

Status: RECRUITING

Clinical Research Site

Chungju, Chungcheongbugdo 27376 - Korea, Republic of

Status: RECRUITING

Clinical Research Site

Cheonan-si, Chungcheongnamdo 31116 - Korea, Republic of

Status: RECRUITING

And 106 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this clinical trial for Rheumatoid Arthritis (RA), Atopic Dermatitis (AD), Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA):

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships